Cargando…

Prognostic Signatures Based on Ferroptosis- and Immune-Related Genes for Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma

Cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC) are among the most common malignancies of the female genital tract. Ferroptosis and immunity regulate each other and play important roles in the progression of CESC. The present study aimed to screen ferroptosis- and immune-rela...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xing, Chaoqun, Yin, Huiming, Yao, Zhi-Yong, Xing, Xiao-Liang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8787259/ https://www.ncbi.nlm.nih.gov/pubmed/35087751 http://dx.doi.org/10.3389/fonc.2021.774558

Ejemplares similares

Identification and validation of a novel necroptosis-related prognostic signature in cervical squamous cell carcinoma and endocervical adenocarcinoma
por: Zhang, Weiyu, et al.
Publicado: (2022)

Development and validation of an autophagy-related long non-coding RNA prognostic signature for cervical squamous cell carcinoma and endocervical adenocarcinoma
por: Zhou, Shuguang, et al.
Publicado: (2022)

Necroptosis-related lncRNA signature predicts prognosis and immune response for cervical squamous cell carcinoma and endocervical adenocarcinomas
por: Lin, Zhiheng, et al.
Publicado: (2022)

Identification and Validation of the Anoikis-Related Gene Signature as a Novel Prognostic Model for Cervical Squamous Cell Carcinoma, Endocervical Adenocarcinoma, and Revelation Immune Infiltration
por: Jin, Qin-Qin, et al.
Publicado: (2023)

Prognostic Significance of Alternative Splicing Genes in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma
por: Wang, Xiaoyu, et al.
Publicado: (2021)

Prognostic Value and Immune Infiltration of HPV-Related Genes in the Immune Microenvironment of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma
por: Gan, Qiyu, et al.
Publicado: (2023)

The New Biomarker for Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (CESC) Based on Public Database Mining
por: Ding, Hao, et al.
Publicado: (2020)

Immune-Related lncRNAs to Construct Novel Signatures and Predict the Prognosis of Rectal Cancer
por: Xing, Xiao-Liang, et al.
Publicado: (2021)

Prediction of Prognosis and Chemotherapeutic Sensitivity Based on Cuproptosis-Associated lncRNAs in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma
por: Zhou, Jianghong, et al.
Publicado: (2023)

MLK4 as an immune marker and its correlation with immune infiltration in Cervical squamous cell carcinoma and endocervical adenocarcinoma(CESC)
por: Gong, Meng, et al.
Publicado: (2023)

Prognostic Value of an Immune-Related Gene Signature in Oral Squamous Cell Carcinoma
por: Zhu, Chao, et al.
Publicado: (2021)

Establishing a prognostic model of ferroptosis- and immune-related signatures in kidney cancer: A study based on TCGA and ICGC databases
por: Han, Zhijun, et al.
Publicado: (2022)

Development and Validation of Ferroptosis- and Immune-Related lncRNAs Signatures for Breast Infiltrating Duct and Lobular Carcinoma
por: Wei, Tao, et al.
Publicado: (2022)

Identification of Stemness-Related Genes for Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma by Integrated Bioinformatics Analysis
por: Guo, Hongjun, et al.
Publicado: (2021)

Development and validation of ferroptosis-related lncRNAs prognosis signatures in kidney renal clear cell carcinoma
por: Xing, Xiao-Liang, et al.
Publicado: (2021)

Down-regulation of S1PR2 is correlated with poor prognosis and immune infiltrates in cervical squamous cell carcinoma and endocervical adenocarcinoma
por: Zhang, Yu, et al.
Publicado: (2023)

The Ferroptosis-Related Noncoding RNA Signature as a Novel Prognostic Biomarker in the Tumor Microenvironment, Immunotherapy, and Drug Screening of Gastric Adenocarcinoma
por: Chen, Xinming, et al.
Publicado: (2021)

Clinical Significance and Immune Landscape of Recurrence-Associated Ferroptosis Signature in Early-Stage Lung Adenocarcinoma
por: Yi, Lilan, et al.
Publicado: (2022)

Establishment and validation of a ferroptosis-related prognostic signature for hepatocellular carcinoma
por: He, Yixian, et al.
Publicado: (2023)

Prognostic implications of ferroptosis-associated gene signature in colon adenocarcinoma
por: Miao, Yan-Dong, et al.
Publicado: (2021)

An Integrated Analysis of Prognostic Signature and Immune Microenvironment in Tongue Squamous Cell Carcinoma
por: Jin, Yi, et al.
Publicado: (2022)

Immune-Related lncRNA Pairs as Prognostic Signature and Immune-Landscape Predictor in Lung Adenocarcinoma
por: Yin, Zhengrong, et al.
Publicado: (2022)

Development and Validation of an Immune-Related Prognostic Signature in Cervical Cancer
por: Su, Rongjia, et al.
Publicado: (2022)

Novel Prognostic Biomarkers for Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (CESC) Patients via Analysis of Competing Endogenous RNA (ceRNA) Network
por: Dong, Yanru, et al.
Publicado: (2023)

A Novel Prognostic Model Based on Ferroptosis-Related Gene Signature for Bladder Cancer
por: Yang, Libo, et al.
Publicado: (2021)

Development and Validation of a Robust Immune Prognostic Signature for Head and Neck Squamous Cell Carcinoma
por: Qiu, Yu, et al.
Publicado: (2020)

Retracted: Novel Prognostic Biomarkers for Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (CESC) Patients via Analysis of Competing Endogenous RNA (ceRNA) Network
por: Markers, Disease
Publicado: (2023)

Development of a Prognostic Alternative Splicing Signature Associated With Tumor Microenvironment Immune Profiles in Lung Adenocarcinoma
por: Bao, Guangyao, et al.
Publicado: (2022)

Identification of a Ferroptosis-Related Signature Model Including mRNAs and lncRNAs for Predicting Prognosis and Immune Activity in Hepatocellular Carcinoma
por: Chen, Zi-An, et al.
Publicado: (2021)

Identification and Validation of a Four-Gene Ferroptosis Signature for Predicting Overall Survival of Lung Squamous Cell Carcinoma
por: Wang, Qi, et al.
Publicado: (2022)

Identification and Validation of an Apoptosis-Related Gene Prognostic Signature for Oral Squamous Cell Carcinoma
por: Wang, Shuqin, et al.
Publicado: (2022)

Identification of a Novel Ferroptosis-Related Gene Prognostic Signature in Bladder Cancer
por: Sun, Jiale, et al.
Publicado: (2021)

Development and validation of a combined hypoxia and ferroptosis prognostic signature for breast cancer
por: Zhong, Jianxin, et al.
Publicado: (2023)

Identification of a prognostic ferroptosis-related lncRNA signature in the tumor microenvironment of lung adenocarcinoma
por: Guo, Yugang, et al.
Publicado: (2021)

The Prognostic Signature of Head and Neck Squamous Cell Carcinoma Constructed by Immune-Related RNA-Binding Proteins
por: Ming, Ruijie, et al.
Publicado: (2022)

Development and Validation of a Prognostic Signature Based on Immune Genes in Cervical Cancer
por: Chen, Yu, et al.
Publicado: (2021)

Development and validation of a combined ferroptosis and immune prognostic signature for lung adenocarcinoma
por: Li, Han, et al.
Publicado: (2022)

Pulmonary microbiota signatures adjacent to adenocarcinoma, squamous cell carcinoma and benign lesion
por: Li, Jinyou, et al.
Publicado: (2023)

Construction of a Novel Ferroptosis-Related Gene Signature for Predicting Survival of Patients With Lung Adenocarcinoma
por: Song, Xiaojie, et al.
Publicado: (2022)

Development and Validation of an m6A RNA Methylation Regulator-Based Signature for Prognostic Prediction in Cervical Squamous Cell Carcinoma
por: Pan, Jingxin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7m2g4h86p2nus169c1b0kg18e8